Evaluation of cardiovascular risk in renal transplant recipients: clinical importance according to the framingham score
International Journal of Development Research
Evaluation of cardiovascular risk in renal transplant recipients: clinical importance according to the framingham score
Received 18th April, 2020; Received in revised form 26th May, 2020; Accepted 08th June, 2020; Published online 30th July, 2020
Copyright © 2020, Maiara Vanusa Guedes Ribeiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: Chronic kidney disease belongs to chronic non-communicable diseases. It is understood as a clinical syndrome characterized by a significant reduction in excretory, endocrine and metabolic renal functions. Cardiovascular disease is responsible for a large part of the mortality and comorbidity present in patients with kidney transplantation. Objectives: To identify the profile of renal transplant recipients and estimate the risk of future cardiovascular events. Methods: Observational, descriptive and analytical study with a quantitative approach, developed at the Renal do Oeste clinic in Santa Catarina, a reference for renal treatment. Results: It was possible to identify in patients with kidney transplantation some factors that influence the development of cardiovascular disease, factors such as: biochemical parameters and anthropometric measurements. Since, the parameters of lipid profile, triglycerides, systolic blood pressure, C-reactive protein and Framingham Risk Score showed a significant difference between groups. Conclusion: The application of the Framingham risk score generates important and necessary information in order to reduce the risk of developing cardiovascular disease, directly resulting in an increase in the quality of life and survival of patients after kidney transplantation.